Sage Journals: Discover world-class research

Abstract

Keywords

Antibiotics,New Biologicals,New Diabetes,Use of Oral Drugs Drug Combinations Drug Compendium Drug Efficacy Study Drugs,Investigational Drugs,New Duplicate Single Drugs Foreign Countries,New Drugs 1970 Investigational New Drug Applications (IND)New Drug Applications (NDA)Research,Drug U.S. Food and Drug Administration,New Drugs 1970

Get full access to this article

View all access options for this article.

References

Cotzias

G. C.

Van Woert

M. H.

Schiffer

L. M.

: Aromatic Amino Acids and Modification of Parkinsonism, New Engl, J. Med. 276: 374–379 (Feb. 16) 1967.

Cotzias

G. C.

Papavasilious

P. S.

Gellene

: Modification of Parkinsonism — Chronic Treatment with L-Dopa, New Engl. J. Med. 280: 337–345 (Feb. 13) 1969.

Yahr

M. D.

Duvoisin

R. C.

Schear

M. J.

Barrett

R. E.

Hoehn

M. M.

: Treatment of Parkinsonism with Levodopa, Arch. Neurol, 21: 343–354 (Oct.) 1969.

Barbeau

Andre

: Parkinson's Disease, Recent Advances in Treatment, N. Y. J. Med. 70: 2437–2443 (Oct. 1) 1970.

Federal Register (Sept. 23) 1970; F. R. 14784.

Cade

John J. F.

: Lithium Salts in the Treatment of Psychotic Excitement, Med. J. Australia 2: 349, 1949.

Sugerman

A. A.

: Comparison of TPS-23 and Thioridazine in Chronic Schizophrenic Patients, Current Therap. Res. 7: 520–527 (Sept. 9) 1965.

Goldstein

B. J.

Dippy

W. E.

: A Clinical Evaluation of Mesoridazine (Serentil) in Geriatric Patients, Current Therap. Res. 9: 256–260 (May) 1967.

Lowenstam

: The Effect of Mesoridazine, A New Thioridazine Derivative, in Alcoholics: A Preliminary Study, J. Clin. Pharmacol. 7: 111–115 (Mar.-Apr.) 1967.

10.

MacDonald

H. R.

Braid

D. P.

Stead

B. R.

Crawford

I. C.

Taylor

S. H.

: Clinical and Circulatory Effects of Neuroleptanalgesia with Dehydrobenzperidol and Phenoperidine, Brit. Heart J. 28: 654–662 (Sept.) 1966.

11.

Fox

J. W. C.

Fox

E. J.

Crandell

D. L. R.

: Neuroleptanalgesia for Heart and Major Surgery, Arch. Surg. 94: 102–106 (Jan.) 1967.

12.

Stephen

C. R.

: Premedication with Droperidol, Amer. Med. Assoc. 118 Mtg. 1969: (July) 1969.

13.

Jick

: Comparative Studies with a Hypnotic (Ro 5-6901) under Current Investigation, Current Therap. Res. 9: 355–357 (July) 1967.

14.

Corssen

Miyasaka

Domino

E. F.

: Changing Concepts in Pain Control During Surgery: Dissociative Anesthesia with CI-581. A Progress Report, Anesthesia Analgesia 47: 746–759 (Nov.-Dec.) 1968.

15.

Mann

J. G.

Shaw

C. W.

Cooper

F. G.

Davis

D. J.

(G. P. Group, Wellington, Salop, Eng.): A Clinical Trial of a New Topical Steroid, Locorten (Flumethasone Pivalate — 27913-Ba), Brit. J. Clin. Pract. 20: 25–26 (Jan.) 1966.

16.

15a Grater

W. C.

Grover

F. W.

: Evolution of a Topical Corticosteroid (Flumethasone Pivalate) in Allergic Dermatoses, Southern Med, J. 60: 1153–1158 (Nov.) 1967.

17.

Ferin

Renaer

: Treatment of Anovulatory Infertility with Human Menopausal Gonadotropin Followed by Human Chorionic Gonadotropin, Am. J. Obstet. Gynecol. 101: 439–447 (June 15) 1968.

18.

Kaiser

Daume

Lang

: Ovulationsauslosung mit Clomiphen und Gonadotropinen, Munchen. Med. Wochschr. 110: 2741–2748 (Nov. 22) 1968.

19.

Hung

: Treatment of Diabetes Insipidus in Children with Synthetic Lysine-8-Vasopressin Nasal Spray, Med. Ann. D. C. 36: 400–401 (July) 1967.

20.

Mimica

Wegienka

L. C.

Forsham

P. H.

: Lypressin Nasal Spray. Usefulness in Patients Who Manifest Allergies to Other Antidiuretic Hormone Preparations, J. Am. Med. Assoc. 203: 802–803 (Feb. 26) 1968.

21.

Bronstein

DeFelice

E. A.

Long

: Evaluation of Lysine-8-Vasopressin Nasal Spray in 641 Patients with Diabetes Insipidus, J. Am. Med. Assoc. 208: 1481 [Abstr. 38] (May 26) 1969.

22.

Stratford

B. C.

: The Treatment of Infections Due to Pseudomonas aeruginosa with Carbenicillin (“Pyopen”), Med. J. Australia 2: 890–895 (Nov. 16) 1968.

23.

Bodey

G. P.

Rodriguez

Luce

J. K.

: Carbenicillin Therapy of Gram-Negative Bacilli Infections, Am. J. Med. Sci. 257: 408–414 (June) 1969.

24.

Gritz

Naumann

: Klinische Erfahrungen bei der Behandlung von Pyocyaneus-Infektionen der Harnwege mit Carbenicillin, Arzneimittel Forsch. 19: 1237–1241 (Aug.) 1969.

25.

Lurie

Ogilvie

Townsend

Gold

Meyers

A. M.

Goldberg

: Carbenicillin-Induced Coagulopathy (Letters to Editor), Lancet 1: 1114–1115 (May 23) 1970.

26.

Landes

R. R.

Melnick

Fletcher

McCormick

: Cephaloglycin: A New Orally Effective Antibiotic for Urinary Tract Infections, J. Urol. 102: 246–248 (Aug.) 1969.

27.

Randolph

M. F.

Redys

J. J.

Hibbard

E. W.

: Streptococcal Pharyngitis. III. Streptococcal Recurrence Rates Following Therapy with Penicillin or with Clindamycin (7-Chlorolincomycin), Delaware Med. J. 42: 87–92 (Apr.) 1970.

28.

Koons

C. R.

Sensenbrenner

L. L.

Owens

A. H.

: Clinical Studies of Mithramycin in Patients with Embryonal Cancer, Bull. Johns Hopkins Hosp. 118: 462–475 (June) 1966.

29.

Hutter

A. M.

Kayhoe

D. E.

: Adrenal Cortical Carcinoma. Results of Treatment with o, p'DDD in 138 Patients, Am. J. Med. 41: 581–592 (Oct.) 1966.

30.

Drug Efficacy Study: National Academy of Sciences, Washington, D. C. 1969.

31.

The University Group Diabetes Program: Diabetes, Vol. 19 Suppl. 2 (1970).

32.

Bloom

: Are Antidiabetic Drugs Dangerous?, Brit. Med. J. 4: 617–618 (Dec. 5) 1970.

33.

Editorial: Are Antidiabetic Drugs Dangerous?, Brit. Med. J. 4: 444–445 (Nov. 21) 1970.

34.

Sutherland

E. W.

: On the Biological Role of Cyclic AMP, J. Am. Med. Assoc. 214: 1281–1288 (Nov. 16) 1970.

35.

Schoenhoefer

, Editorial: Cyclic Adenosin-3′,5′-Monophosphate (Cyclic AMP), Praxis 59: 1623–1625 (Nov. 24) 1970.

36.

Food and Drug Administration: Bureau of Drugs, Office of Scientific Evaluation, Personal Communication.

37.

Finkel

M. J.

Zatman

: Investigational and New Drugs, FDA Papers 4: 31–33 (Nov.) 1970.

38.

Annual Survey Report: Pharmaceutical Manufacturers Association, Washington, D. C., 1969–70.

Annual Review of New Drugs

Abstract

Keywords

Get full access to this article

References